Barry Bernstein

10.1k total citations · 6 hit papers
139 papers, 7.7k citations indexed

About

Barry Bernstein is a scholar working on Biomedical Engineering, Fluid Flow and Transfer Processes and Infectious Diseases. According to data from OpenAlex, Barry Bernstein has authored 139 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Biomedical Engineering, 33 papers in Fluid Flow and Transfer Processes and 32 papers in Infectious Diseases. Recurrent topics in Barry Bernstein's work include Rheology and Fluid Dynamics Studies (32 papers), HIV/AIDS drug development and treatment (31 papers) and Elasticity and Material Modeling (27 papers). Barry Bernstein is often cited by papers focused on Rheology and Fluid Dynamics Studies (32 papers), HIV/AIDS drug development and treatment (31 papers) and Elasticity and Material Modeling (27 papers). Barry Bernstein collaborates with scholars based in United States, United Kingdom and Canada. Barry Bernstein's co-authors include L. J. Zapas, Martin King, E. A. Kearsley, R. A. Toupin, Thomas Podsadecki, Kris V. Kowdley, Eugene Sun, Dale J. Kempf, Lois Larsen and Edward Tam and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Gastroenterology.

In The Last Decade

Barry Bernstein

137 papers receiving 7.4k citations

Hit Papers

Treatment of H... 1963 2026 1984 2005 2014 2014 1963 2002 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
    2014 686 citations Jordan J. Feld, Kris V. Kowdley et al. New England Journal of Medicine profile →
  2. ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
    2014 646 citations Fred Poordad, Kris V. Kowdley et al. New England Journal of Medicine profile →
  3. A Study of Stress Relaxation with Finite Strain
    1963 558 citations Barry Bernstein et al. profile →
  4. Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
    2002 518 citations Sharon Walmsley, Barry Bernstein et al. New England Journal of Medicine profile →
  5. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
    2008 514 citations Barry Bernstein, Scott C. Brun et al. profile →
  6. Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
    2014 395 citations Stefan Zeuzem, Fred Poordad et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Bernstein United States 36 3.0k 2.8k 2.7k 1.9k 814 139 7.7k
Bartley P. Griffith United States 84 878 0.3× 1.1k 0.4× 5.2k 1.9× 142 0.1× 80 0.1× 704 28.4k
John A. Lewis United States 48 1.1k 0.4× 654 0.2× 1.4k 0.5× 814 0.4× 11 0.0× 174 11.4k
Sudhakar K. Venkatesh United States 51 493 0.2× 3.6k 1.3× 4.7k 1.7× 19 0.0× 56 0.1× 341 9.0k
Yimin Li China 42 2.5k 0.8× 142 0.1× 941 0.3× 29 0.0× 17 0.0× 414 10.3k
Robert L. Murphy United States 62 7.2k 2.4× 669 0.2× 3.5k 1.3× 5.6k 3.0× 417 14.6k
Christoph F. Dietrich Germany 58 535 0.2× 3.1k 1.1× 3.6k 1.3× 6 0.0× 17 0.0× 490 12.8k
Cesare Hassan Italy 80 521 0.2× 491 0.2× 1.7k 0.6× 18 0.0× 12 0.0× 745 25.6k
Grover M. Hutchins United States 79 805 0.3× 480 0.2× 3.4k 1.2× 29 0.0× 47 0.1× 417 20.5k
Yoshinao Kobayashi Japan 36 176 0.1× 992 0.3× 1.3k 0.5× 21 0.0× 21 0.0× 223 4.4k
Evan S. Dellon United States 68 542 0.2× 248 0.1× 926 0.3× 199 0.1× 7 0.0× 652 19.7k

Countries citing papers authored by Barry Bernstein

Since Specialization
Citations

This map shows the geographic impact of Barry Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Bernstein more than expected).

Fields of papers citing papers by Barry Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Bernstein. The network helps show where Barry Bernstein may publish in the future.

Co-authorship network of co-authors of Barry Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Bernstein. A scholar is included among the top collaborators of Barry Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Bernstein. Barry Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feld, Jordan J., Kris V. Kowdley, Eoin Coakley, et al.. (2014). Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin. New England Journal of Medicine. 370(17). 1594–1603. 686 indexed citations breakdown →
2.
Cloherty, Gavin, Daniel E. Cohen, Christoph Sarrazin, et al.. (2014). HCV RNA Assay Sensitivity Impacts the Management of Patients Treated with Direct-Acting Antivirals. Antiviral Therapy. 20(2). 177–183. 15 indexed citations
3.
Andreoné, Pietro, Massimo Colombo, Jeffrey Enejosa, et al.. (2014). ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection. Gastroenterology. 147(2). 359–365.e1. 273 indexed citations
4.
Kowdley, Kris V., Eric Lawitz, Fred Poordad, et al.. (2014). Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1. New England Journal of Medicine. 370(3). 222–232. 185 indexed citations
5.
Lawitz, Eric, Fred Poordad, Kris V. Kowdley, et al.. (2013). A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. Journal of Hepatology. 59(1). 18–23. 55 indexed citations
6.
Zajdenverg, Roberto, Thomas Podsadecki, Sharlaa Badal‐Faesen, et al.. (2010). Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(2). 143–151. 26 indexed citations
7.
8.
Brown, Todd T., Grace A. McComsey, Martin King, et al.. (2009). Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(5). 554–561. 258 indexed citations
9.
Campo, Rafael, Barbara A. da Silva, Laurent Cotte, et al.. (2009). Predictors of Loss of Virologic Response in Subjects Who Simplified to Lopinavir/Ritonavir Monotherapy from Lopinavir/Ritonavir Plus Zidovudine/Lamivudine. AIDS Research and Human Retroviruses. 25(3). 269–275. 14 indexed citations
10.
Eron, Joseph J., Judith Feinberg, Harold A. Kessler, et al.. (2004). Once‐Daily versus Twice‐Daily Lopinavir/Ritonavir in Antiretroviral‐Naive HIV‐Positive Patients: A 48‐Week Randomized Clinical Trial. The Journal of Infectious Diseases. 189(2). 265–272. 104 indexed citations
11.
King, Martin, Barry Bernstein, Sharon Walmsley, et al.. (2004). Baseline HIV‐1 RNA Level and CD4 Cell Count Predict Time to Loss of Virologic Response to Nelfinavir, but Not Lopinavir/Ritonavir, in Antiretroviral Therapy–Naive Patients. The Journal of Infectious Diseases. 190(2). 280–284. 28 indexed citations
12.
Sáez‐Llorens, Xavier, Richard A. Rode, Edward Handelsman, et al.. (2003). . The Pediatric Infectious Disease Journal. 22(3). 216–223. 5 indexed citations
13.
Sáez‐Llorens, Xavier, Richard A. Rode, Perry Gomez, et al.. (2003). Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 22(3). 216–223. 102 indexed citations
14.
Bertz, Richard, Barry Bernstein, Yi‐Lin Chiu, et al.. (2002). Assessment of the steady-state pharmacokinetic interaction of lopinavir/ritonavir with either indinavir or saquinavir in healthy subjects. 42. 26. 5 indexed citations
15.
Walmsley, Sharon, Barry Bernstein, Martin King, et al.. (2002). Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection. New England Journal of Medicine. 346(26). 2039–2046. 518 indexed citations breakdown →
16.
Gustavson, Linda E., Richard Bertz, Ann Hsu, et al.. (2000). Assessment of the bioequivalence and food effects for liquid and soft elastic capsule co-formulations of ABT-378/ritonavir in healthy subjects. 40. 338. 8 indexed citations
17.
Koller, Elizabeth A., et al.. (1999). Thrombotic events associated with megestrol acetate in patients with AIDS cachexia. Nutrition. 15(4). 294–298. 22 indexed citations
18.
Clair, Alicia Ann & Barry Bernstein. (1994). The Effect of No Music, Stimulative Background Music and Sedative Background Music on Agitated Behaviors in Persons with Severe Dementia. Activities Adaptation & Aging. 19(1). 61–70. 27 indexed citations
19.
Plouffe, Joseph F., Robert L. Perkins, Robert J. Fass, et al.. (1983). Cefotaxime: Pharmacokinetics and in vitro Antibacterial Activity of Serum and Urine in Normal Human Volunteers. Chemotherapy. 29(2). 73–79. 4 indexed citations
20.
Bernstein, Barry, et al.. (1970). Stability of a Relaxation-Type Viscoelastic Fluid with Slight Elasticity. The Physics of Fluids. 13(3). 565–568. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bartley P. Griffith Breakdown of academic impact, for papers by John A. Lewis Breakdown of academic impact, for papers by Sudhakar K. Venkatesh Breakdown of academic impact, for papers by Yimin Li Breakdown of academic impact, for papers by Robert L. Murphy Breakdown of academic impact, for papers by Christoph F. Dietrich Breakdown of academic impact, for papers by Cesare Hassan Breakdown of academic impact, for papers by Grover M. Hutchins Breakdown of academic impact, for papers by Yoshinao Kobayashi Breakdown of academic impact, for papers by Evan S. Dellon
Rankless by CCL
2026